Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭйБиЭл БИО ИНК.filedCriticalЭйБиЭл БИО ИНК.
Priority claimed from PCT/KR2018/014123external-prioritypatent/WO2019098763A2/en
Publication of EA202090961A1publicationCriticalpatent/EA202090961A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Данное изобретение относится к антителам к альфа-синуклеину, предпочтительно распознающим агрегаты альфа-синуклеина, и к применению антител к альфа-синуклеину для обнаружения, диагностики и/или лечения или предупреждения различных заболеваний или симптомов заболеваний, связанных с накоплением агрегатов альфа-синуклеина.This invention relates to antibodies to alpha-synuclein, preferably recognizing aggregates of alpha-synuclein, and to the use of antibodies to alpha-synuclein for the detection, diagnosis and / or treatment or prevention of various diseases or disease symptoms associated with the accumulation of alpha-synuclein aggregates.
EA202090961A2018-06-212018-11-16
ANTIBODIES TO -SYNUCLEINE AND THEIR APPLICATIONS
EA202090961A1
(en)
SPECIFIC MONOCLONAL ANTIBODIES FOR ANTIGEN P OF HUMAN SYNCHRIRY RESPIRATORY VIRUS (VRSH), PRODUCED AND SECRETED BY CELLULAR HYBRIDIDES, USEFUL FOR DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY VRS